Press Releases

 
Adamas Appoints Richard A. King as Chief Operating Officer to Lead Commercialization of ADS-5102
Apr 27, 2017


Adamas Presents ADS-5102 Pooled Phase 3 Data Confirming Statistically Significant Reduction in Levodopa-Induced Dyskinesia and OFF Time in People with Parkinson's Disease
Apr 24, 2017


Adamas Announces Oral and Poster Presentations of ADS-5102 Pooled Phase 3 Data at the 69th American Academy of Neurology Annual Meeting
Apr 18, 2017


Adamas Announces Data Presentation on ADS-5102 at the Academy of Managed Care Pharmacy 2017 Annual Meeting
Mar 28, 2017


Adamas to Present at the 16th Annual Needham Healthcare Conference
Mar 28, 2017


Adamas Announces New Employment Inducement Grant
Mar 10, 2017


Adamas to Present at the 37th Annual Cowen Health Care Conference
Mar 1, 2017


Adamas Reports Recent Achievements and Financial Results for the Fourth Quarter and Full-Year 2016
Feb 28, 2017


Adamas Presents Additional Open-Label, Long-Term Safety and Efficacy Data on ADS-5102 at the First Pan American Parkinson's Disease and Movement Disorders Congress
Feb 28, 2017


Adamas to Present New ADS-5102 Data from Phase 2 Trial in Walking Impairment Associated with Multiple Sclerosis at ACTRIMS Forum 2017
Feb 17, 2017


Page:
1
NextLast